Webinar | April 13, 2023

Animal Models In Ocular Gene Therapy

Source: Charles River
Cell & Gene Therapy Scientists GettyImages-1209892070

While gene therapy considerations and trials date back several decades, technological innovations in recent years have led to a boom in the industry. There are currently over 30 ongoing trials for treatments addressing retinal diseases. However, only one AAV-based ocular gene therapy to date has received regulatory approval. While the pathway for similar products to initial clinical trials ought to be straightforward, it is important to consider the different in vivo studies to conduct and the insights to be gained across various animal models.

Both rodent and non-rodent studies — including non-human primates, rabbits, minipigs, and canines — present benefits and limitations for preclinical studies. Learn more as this webinar shares insights to optimize the path to clinical trials.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.

Subscribe to Drug Delivery Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Delivery Leader